U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Showing 1 - 10 of 15 results

Status:
US Approved Rx (2009)
First approved in 1996

Class (Stereo):
CHEMICAL (ABSOLUTE)



Topiramate is an anticonvulsant indicated in the treatment of epilepsy and migraine. Topiramate enhances GABA-activated chloride channels. In addition, topiramate inhibits excitatory neurotransmission, through actions on kainate and AMPA receptors. T...
Status:
US Approved Rx (1996)
First approved in 1938

Class (Stereo):
CHEMICAL (ACHIRAL)



Phenytoin is an anti-epileptic drug. Phenytoin has been used with much clinical success against all types of epileptiform seizures, except petit mal epilepsy. Phenytoin is a available for oral administration (tablets, capsules, suspension). CEREBYX®...
Status:
Investigational

Class (Stereo):
CHEMICAL (ACHIRAL)


PF-05089771 is an oral administrated Nav1.7 channel inhibitor. PF-05089771 provided the best opportunity to explore Nav1.7 blockade for the treatment of acute or chronic pain conditions. PF-05089771 has completed Phase II clinical trials of third mol...
Status:
US Approved Rx (2009)
First approved in 1996

Class (Stereo):
CHEMICAL (ABSOLUTE)



Topiramate is an anticonvulsant indicated in the treatment of epilepsy and migraine. Topiramate enhances GABA-activated chloride channels. In addition, topiramate inhibits excitatory neurotransmission, through actions on kainate and AMPA receptors. T...
Status:
US Approved Rx (2009)
First approved in 1996

Class (Stereo):
CHEMICAL (ABSOLUTE)



Topiramate is an anticonvulsant indicated in the treatment of epilepsy and migraine. Topiramate enhances GABA-activated chloride channels. In addition, topiramate inhibits excitatory neurotransmission, through actions on kainate and AMPA receptors. T...
Status:
US Approved Rx (2009)
First approved in 1996

Class (Stereo):
CHEMICAL (ABSOLUTE)



Topiramate is an anticonvulsant indicated in the treatment of epilepsy and migraine. Topiramate enhances GABA-activated chloride channels. In addition, topiramate inhibits excitatory neurotransmission, through actions on kainate and AMPA receptors. T...
Status:
US Approved Rx (2009)
First approved in 1996

Class (Stereo):
CHEMICAL (ABSOLUTE)



Topiramate is an anticonvulsant indicated in the treatment of epilepsy and migraine. Topiramate enhances GABA-activated chloride channels. In addition, topiramate inhibits excitatory neurotransmission, through actions on kainate and AMPA receptors. T...
Status:
US Approved Rx (2009)
First approved in 1996

Class (Stereo):
CHEMICAL (ABSOLUTE)



Topiramate is an anticonvulsant indicated in the treatment of epilepsy and migraine. Topiramate enhances GABA-activated chloride channels. In addition, topiramate inhibits excitatory neurotransmission, through actions on kainate and AMPA receptors. T...
Status:
US Approved Rx (2009)
First approved in 1996

Class (Stereo):
CHEMICAL (ABSOLUTE)



Topiramate is an anticonvulsant indicated in the treatment of epilepsy and migraine. Topiramate enhances GABA-activated chloride channels. In addition, topiramate inhibits excitatory neurotransmission, through actions on kainate and AMPA receptors. T...
Status:
US Approved Rx (2009)
First approved in 1996

Class (Stereo):
CHEMICAL (ABSOLUTE)



Topiramate is an anticonvulsant indicated in the treatment of epilepsy and migraine. Topiramate enhances GABA-activated chloride channels. In addition, topiramate inhibits excitatory neurotransmission, through actions on kainate and AMPA receptors. T...

Showing 1 - 10 of 15 results